Brompheniramine Market, Global Outlook and Forecast 2022-2028
Brompheniramine, is an antihistamine drug of the propylamine (alkylamine) class. It is readily available over the counter and is indicated for the treatment of the symptoms of the common cold and allergic rhinitis, such as runny nose, itchy eyes, watery eyes, and sneezing. It is a first-generation antihistamine and one of the drugs of highest anticholinergic activity
This report contains market size and forecasts of Brompheniramine in global, including the following market information:
Global Brompheniramine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Brompheniramine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Brompheniramine companies in 2021 (%)
The global Brompheniramine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Solution Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Brompheniramine include Pfizer, AMAG Pharmaceuticals, PAI, USL Pharma, Watson Laboratories, Teva, Ivax Pharmaceuticals, Newtron Pharmaceuticals and Nexgen Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Brompheniramine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brompheniramine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Brompheniramine Market Segment Percentages, by Type, 2021 (%)
Global Brompheniramine Market Segment Percentages, by Application, 2021 (%)
Global Brompheniramine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Brompheniramine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Brompheniramine revenues share in global market, 2021 (%)
Key companies Brompheniramine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Brompheniramine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Brompheniramine in global, including the following market information:
Global Brompheniramine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Brompheniramine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Brompheniramine companies in 2021 (%)
The global Brompheniramine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Solution Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Brompheniramine include Pfizer, AMAG Pharmaceuticals, PAI, USL Pharma, Watson Laboratories, Teva, Ivax Pharmaceuticals, Newtron Pharmaceuticals and Nexgen Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Brompheniramine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brompheniramine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Brompheniramine Market Segment Percentages, by Type, 2021 (%)
- Oral Solution
- Tablet
Global Brompheniramine Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Drug Store
Global Brompheniramine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Brompheniramine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Brompheniramine revenues share in global market, 2021 (%)
Key companies Brompheniramine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Brompheniramine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- AMAG Pharmaceuticals
- PAI
- USL Pharma
- Watson Laboratories
- Teva
- Ivax Pharmaceuticals
- Newtron Pharmaceuticals
- Nexgen Pharma
- Endo International
- Novartis
- Eon Pharma
- Merck
- Tanta Pharmaceuticals
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Brompheniramine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Brompheniramine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL BROMPHENIRAMINE OVERALL MARKET SIZE
2.1 Global Brompheniramine Market Size: 2021 VS 2028
2.2 Global Brompheniramine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Brompheniramine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Brompheniramine Players in Global Market
3.2 Top Global Brompheniramine Companies Ranked by Revenue
3.3 Global Brompheniramine Revenue by Companies
3.4 Global Brompheniramine Sales by Companies
3.5 Global Brompheniramine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Brompheniramine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Brompheniramine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Brompheniramine Players in Global Market
3.8.1 List of Global Tier 1 Brompheniramine Companies
3.8.2 List of Global Tier 2 and Tier 3 Brompheniramine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Brompheniramine Market Size Markets, 2021 & 2028
4.1.2 Oral Solution
4.1.3 Tablet
4.2 By Type - Global Brompheniramine Revenue & Forecasts
4.2.1 By Type - Global Brompheniramine Revenue, 2017-2022
4.2.2 By Type - Global Brompheniramine Revenue, 2023-2028
4.2.3 By Type - Global Brompheniramine Revenue Market Share, 2017-2028
4.3 By Type - Global Brompheniramine Sales & Forecasts
4.3.1 By Type - Global Brompheniramine Sales, 2017-2022
4.3.2 By Type - Global Brompheniramine Sales, 2023-2028
4.3.3 By Type - Global Brompheniramine Sales Market Share, 2017-2028
4.4 By Type - Global Brompheniramine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Brompheniramine Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Drug Store
5.2 By Application - Global Brompheniramine Revenue & Forecasts
5.2.1 By Application - Global Brompheniramine Revenue, 2017-2022
5.2.2 By Application - Global Brompheniramine Revenue, 2023-2028
5.2.3 By Application - Global Brompheniramine Revenue Market Share, 2017-2028
5.3 By Application - Global Brompheniramine Sales & Forecasts
5.3.1 By Application - Global Brompheniramine Sales, 2017-2022
5.3.2 By Application - Global Brompheniramine Sales, 2023-2028
5.3.3 By Application - Global Brompheniramine Sales Market Share, 2017-2028
5.4 By Application - Global Brompheniramine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Brompheniramine Market Size, 2021 & 2028
6.2 By Region - Global Brompheniramine Revenue & Forecasts
6.2.1 By Region - Global Brompheniramine Revenue, 2017-2022
6.2.2 By Region - Global Brompheniramine Revenue, 2023-2028
6.2.3 By Region - Global Brompheniramine Revenue Market Share, 2017-2028
6.3 By Region - Global Brompheniramine Sales & Forecasts
6.3.1 By Region - Global Brompheniramine Sales, 2017-2022
6.3.2 By Region - Global Brompheniramine Sales, 2023-2028
6.3.3 By Region - Global Brompheniramine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Brompheniramine Revenue, 2017-2028
6.4.2 By Country - North America Brompheniramine Sales, 2017-2028
6.4.3 US Brompheniramine Market Size, 2017-2028
6.4.4 Canada Brompheniramine Market Size, 2017-2028
6.4.5 Mexico Brompheniramine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Brompheniramine Revenue, 2017-2028
6.5.2 By Country - Europe Brompheniramine Sales, 2017-2028
6.5.3 Germany Brompheniramine Market Size, 2017-2028
6.5.4 France Brompheniramine Market Size, 2017-2028
6.5.5 U.K. Brompheniramine Market Size, 2017-2028
6.5.6 Italy Brompheniramine Market Size, 2017-2028
6.5.7 Russia Brompheniramine Market Size, 2017-2028
6.5.8 Nordic Countries Brompheniramine Market Size, 2017-2028
6.5.9 Benelux Brompheniramine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Brompheniramine Revenue, 2017-2028
6.6.2 By Region - Asia Brompheniramine Sales, 2017-2028
6.6.3 China Brompheniramine Market Size, 2017-2028
6.6.4 Japan Brompheniramine Market Size, 2017-2028
6.6.5 South Korea Brompheniramine Market Size, 2017-2028
6.6.6 Southeast Asia Brompheniramine Market Size, 2017-2028
6.6.7 India Brompheniramine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Brompheniramine Revenue, 2017-2028
6.7.2 By Country - South America Brompheniramine Sales, 2017-2028
6.7.3 Brazil Brompheniramine Market Size, 2017-2028
6.7.4 Argentina Brompheniramine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Brompheniramine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Brompheniramine Sales, 2017-2028
6.8.3 Turkey Brompheniramine Market Size, 2017-2028
6.8.4 Israel Brompheniramine Market Size, 2017-2028
6.8.5 Saudi Arabia Brompheniramine Market Size, 2017-2028
6.8.6 UAE Brompheniramine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Brompheniramine Major Product Offerings
7.1.4 Pfizer Brompheniramine Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 AMAG Pharmaceuticals
7.2.1 AMAG Pharmaceuticals Corporate Summary
7.2.2 AMAG Pharmaceuticals Business Overview
7.2.3 AMAG Pharmaceuticals Brompheniramine Major Product Offerings
7.2.4 AMAG Pharmaceuticals Brompheniramine Sales and Revenue in Global (2017-2022)
7.2.5 AMAG Pharmaceuticals Key News
7.3 PAI
7.3.1 PAI Corporate Summary
7.3.2 PAI Business Overview
7.3.3 PAI Brompheniramine Major Product Offerings
7.3.4 PAI Brompheniramine Sales and Revenue in Global (2017-2022)
7.3.5 PAI Key News
7.4 USL Pharma
7.4.1 USL Pharma Corporate Summary
7.4.2 USL Pharma Business Overview
7.4.3 USL Pharma Brompheniramine Major Product Offerings
7.4.4 USL Pharma Brompheniramine Sales and Revenue in Global (2017-2022)
7.4.5 USL Pharma Key News
7.5 Watson Laboratories
7.5.1 Watson Laboratories Corporate Summary
7.5.2 Watson Laboratories Business Overview
7.5.3 Watson Laboratories Brompheniramine Major Product Offerings
7.5.4 Watson Laboratories Brompheniramine Sales and Revenue in Global (2017-2022)
7.5.5 Watson Laboratories Key News
7.6 Teva
7.6.1 Teva Corporate Summary
7.6.2 Teva Business Overview
7.6.3 Teva Brompheniramine Major Product Offerings
7.6.4 Teva Brompheniramine Sales and Revenue in Global (2017-2022)
7.6.5 Teva Key News
7.7 Ivax Pharmaceuticals
7.7.1 Ivax Pharmaceuticals Corporate Summary
7.7.2 Ivax Pharmaceuticals Business Overview
7.7.3 Ivax Pharmaceuticals Brompheniramine Major Product Offerings
7.7.4 Ivax Pharmaceuticals Brompheniramine Sales and Revenue in Global (2017-2022)
7.7.5 Ivax Pharmaceuticals Key News
7.8 Newtron Pharmaceuticals
7.8.1 Newtron Pharmaceuticals Corporate Summary
7.8.2 Newtron Pharmaceuticals Business Overview
7.8.3 Newtron Pharmaceuticals Brompheniramine Major Product Offerings
7.8.4 Newtron Pharmaceuticals Brompheniramine Sales and Revenue in Global (2017-2022)
7.8.5 Newtron Pharmaceuticals Key News
7.9 Nexgen Pharma
7.9.1 Nexgen Pharma Corporate Summary
7.9.2 Nexgen Pharma Business Overview
7.9.3 Nexgen Pharma Brompheniramine Major Product Offerings
7.9.4 Nexgen Pharma Brompheniramine Sales and Revenue in Global (2017-2022)
7.9.5 Nexgen Pharma Key News
7.10 Endo International
7.10.1 Endo International Corporate Summary
7.10.2 Endo International Business Overview
7.10.3 Endo International Brompheniramine Major Product Offerings
7.10.4 Endo International Brompheniramine Sales and Revenue in Global (2017-2022)
7.10.5 Endo International Key News
7.11 Novartis
7.11.1 Novartis Corporate Summary
7.11.2 Novartis Brompheniramine Business Overview
7.11.3 Novartis Brompheniramine Major Product Offerings
7.11.4 Novartis Brompheniramine Sales and Revenue in Global (2017-2022)
7.11.5 Novartis Key News
7.12 Eon Pharma
7.12.1 Eon Pharma Corporate Summary
7.12.2 Eon Pharma Brompheniramine Business Overview
7.12.3 Eon Pharma Brompheniramine Major Product Offerings
7.12.4 Eon Pharma Brompheniramine Sales and Revenue in Global (2017-2022)
7.12.5 Eon Pharma Key News
7.13 Merck
7.13.1 Merck Corporate Summary
7.13.2 Merck Brompheniramine Business Overview
7.13.3 Merck Brompheniramine Major Product Offerings
7.13.4 Merck Brompheniramine Sales and Revenue in Global (2017-2022)
7.13.5 Merck Key News
7.14 Tanta Pharmaceuticals
7.14.1 Tanta Pharmaceuticals Corporate Summary
7.14.2 Tanta Pharmaceuticals Business Overview
7.14.3 Tanta Pharmaceuticals Brompheniramine Major Product Offerings
7.14.4 Tanta Pharmaceuticals Brompheniramine Sales and Revenue in Global (2017-2022)
7.14.5 Tanta Pharmaceuticals Key News
8 GLOBAL BROMPHENIRAMINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Brompheniramine Production Capacity, 2017-2028
8.2 Brompheniramine Production Capacity of Key Manufacturers in Global Market
8.3 Global Brompheniramine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 BROMPHENIRAMINE SUPPLY CHAIN ANALYSIS
10.1 Brompheniramine Industry Value Chain
10.2 Brompheniramine Upstream Market
10.3 Brompheniramine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Brompheniramine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Brompheniramine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Brompheniramine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL BROMPHENIRAMINE OVERALL MARKET SIZE
2.1 Global Brompheniramine Market Size: 2021 VS 2028
2.2 Global Brompheniramine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Brompheniramine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Brompheniramine Players in Global Market
3.2 Top Global Brompheniramine Companies Ranked by Revenue
3.3 Global Brompheniramine Revenue by Companies
3.4 Global Brompheniramine Sales by Companies
3.5 Global Brompheniramine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Brompheniramine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Brompheniramine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Brompheniramine Players in Global Market
3.8.1 List of Global Tier 1 Brompheniramine Companies
3.8.2 List of Global Tier 2 and Tier 3 Brompheniramine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Brompheniramine Market Size Markets, 2021 & 2028
4.1.2 Oral Solution
4.1.3 Tablet
4.2 By Type - Global Brompheniramine Revenue & Forecasts
4.2.1 By Type - Global Brompheniramine Revenue, 2017-2022
4.2.2 By Type - Global Brompheniramine Revenue, 2023-2028
4.2.3 By Type - Global Brompheniramine Revenue Market Share, 2017-2028
4.3 By Type - Global Brompheniramine Sales & Forecasts
4.3.1 By Type - Global Brompheniramine Sales, 2017-2022
4.3.2 By Type - Global Brompheniramine Sales, 2023-2028
4.3.3 By Type - Global Brompheniramine Sales Market Share, 2017-2028
4.4 By Type - Global Brompheniramine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Brompheniramine Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Drug Store
5.2 By Application - Global Brompheniramine Revenue & Forecasts
5.2.1 By Application - Global Brompheniramine Revenue, 2017-2022
5.2.2 By Application - Global Brompheniramine Revenue, 2023-2028
5.2.3 By Application - Global Brompheniramine Revenue Market Share, 2017-2028
5.3 By Application - Global Brompheniramine Sales & Forecasts
5.3.1 By Application - Global Brompheniramine Sales, 2017-2022
5.3.2 By Application - Global Brompheniramine Sales, 2023-2028
5.3.3 By Application - Global Brompheniramine Sales Market Share, 2017-2028
5.4 By Application - Global Brompheniramine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Brompheniramine Market Size, 2021 & 2028
6.2 By Region - Global Brompheniramine Revenue & Forecasts
6.2.1 By Region - Global Brompheniramine Revenue, 2017-2022
6.2.2 By Region - Global Brompheniramine Revenue, 2023-2028
6.2.3 By Region - Global Brompheniramine Revenue Market Share, 2017-2028
6.3 By Region - Global Brompheniramine Sales & Forecasts
6.3.1 By Region - Global Brompheniramine Sales, 2017-2022
6.3.2 By Region - Global Brompheniramine Sales, 2023-2028
6.3.3 By Region - Global Brompheniramine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Brompheniramine Revenue, 2017-2028
6.4.2 By Country - North America Brompheniramine Sales, 2017-2028
6.4.3 US Brompheniramine Market Size, 2017-2028
6.4.4 Canada Brompheniramine Market Size, 2017-2028
6.4.5 Mexico Brompheniramine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Brompheniramine Revenue, 2017-2028
6.5.2 By Country - Europe Brompheniramine Sales, 2017-2028
6.5.3 Germany Brompheniramine Market Size, 2017-2028
6.5.4 France Brompheniramine Market Size, 2017-2028
6.5.5 U.K. Brompheniramine Market Size, 2017-2028
6.5.6 Italy Brompheniramine Market Size, 2017-2028
6.5.7 Russia Brompheniramine Market Size, 2017-2028
6.5.8 Nordic Countries Brompheniramine Market Size, 2017-2028
6.5.9 Benelux Brompheniramine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Brompheniramine Revenue, 2017-2028
6.6.2 By Region - Asia Brompheniramine Sales, 2017-2028
6.6.3 China Brompheniramine Market Size, 2017-2028
6.6.4 Japan Brompheniramine Market Size, 2017-2028
6.6.5 South Korea Brompheniramine Market Size, 2017-2028
6.6.6 Southeast Asia Brompheniramine Market Size, 2017-2028
6.6.7 India Brompheniramine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Brompheniramine Revenue, 2017-2028
6.7.2 By Country - South America Brompheniramine Sales, 2017-2028
6.7.3 Brazil Brompheniramine Market Size, 2017-2028
6.7.4 Argentina Brompheniramine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Brompheniramine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Brompheniramine Sales, 2017-2028
6.8.3 Turkey Brompheniramine Market Size, 2017-2028
6.8.4 Israel Brompheniramine Market Size, 2017-2028
6.8.5 Saudi Arabia Brompheniramine Market Size, 2017-2028
6.8.6 UAE Brompheniramine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Brompheniramine Major Product Offerings
7.1.4 Pfizer Brompheniramine Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 AMAG Pharmaceuticals
7.2.1 AMAG Pharmaceuticals Corporate Summary
7.2.2 AMAG Pharmaceuticals Business Overview
7.2.3 AMAG Pharmaceuticals Brompheniramine Major Product Offerings
7.2.4 AMAG Pharmaceuticals Brompheniramine Sales and Revenue in Global (2017-2022)
7.2.5 AMAG Pharmaceuticals Key News
7.3 PAI
7.3.1 PAI Corporate Summary
7.3.2 PAI Business Overview
7.3.3 PAI Brompheniramine Major Product Offerings
7.3.4 PAI Brompheniramine Sales and Revenue in Global (2017-2022)
7.3.5 PAI Key News
7.4 USL Pharma
7.4.1 USL Pharma Corporate Summary
7.4.2 USL Pharma Business Overview
7.4.3 USL Pharma Brompheniramine Major Product Offerings
7.4.4 USL Pharma Brompheniramine Sales and Revenue in Global (2017-2022)
7.4.5 USL Pharma Key News
7.5 Watson Laboratories
7.5.1 Watson Laboratories Corporate Summary
7.5.2 Watson Laboratories Business Overview
7.5.3 Watson Laboratories Brompheniramine Major Product Offerings
7.5.4 Watson Laboratories Brompheniramine Sales and Revenue in Global (2017-2022)
7.5.5 Watson Laboratories Key News
7.6 Teva
7.6.1 Teva Corporate Summary
7.6.2 Teva Business Overview
7.6.3 Teva Brompheniramine Major Product Offerings
7.6.4 Teva Brompheniramine Sales and Revenue in Global (2017-2022)
7.6.5 Teva Key News
7.7 Ivax Pharmaceuticals
7.7.1 Ivax Pharmaceuticals Corporate Summary
7.7.2 Ivax Pharmaceuticals Business Overview
7.7.3 Ivax Pharmaceuticals Brompheniramine Major Product Offerings
7.7.4 Ivax Pharmaceuticals Brompheniramine Sales and Revenue in Global (2017-2022)
7.7.5 Ivax Pharmaceuticals Key News
7.8 Newtron Pharmaceuticals
7.8.1 Newtron Pharmaceuticals Corporate Summary
7.8.2 Newtron Pharmaceuticals Business Overview
7.8.3 Newtron Pharmaceuticals Brompheniramine Major Product Offerings
7.8.4 Newtron Pharmaceuticals Brompheniramine Sales and Revenue in Global (2017-2022)
7.8.5 Newtron Pharmaceuticals Key News
7.9 Nexgen Pharma
7.9.1 Nexgen Pharma Corporate Summary
7.9.2 Nexgen Pharma Business Overview
7.9.3 Nexgen Pharma Brompheniramine Major Product Offerings
7.9.4 Nexgen Pharma Brompheniramine Sales and Revenue in Global (2017-2022)
7.9.5 Nexgen Pharma Key News
7.10 Endo International
7.10.1 Endo International Corporate Summary
7.10.2 Endo International Business Overview
7.10.3 Endo International Brompheniramine Major Product Offerings
7.10.4 Endo International Brompheniramine Sales and Revenue in Global (2017-2022)
7.10.5 Endo International Key News
7.11 Novartis
7.11.1 Novartis Corporate Summary
7.11.2 Novartis Brompheniramine Business Overview
7.11.3 Novartis Brompheniramine Major Product Offerings
7.11.4 Novartis Brompheniramine Sales and Revenue in Global (2017-2022)
7.11.5 Novartis Key News
7.12 Eon Pharma
7.12.1 Eon Pharma Corporate Summary
7.12.2 Eon Pharma Brompheniramine Business Overview
7.12.3 Eon Pharma Brompheniramine Major Product Offerings
7.12.4 Eon Pharma Brompheniramine Sales and Revenue in Global (2017-2022)
7.12.5 Eon Pharma Key News
7.13 Merck
7.13.1 Merck Corporate Summary
7.13.2 Merck Brompheniramine Business Overview
7.13.3 Merck Brompheniramine Major Product Offerings
7.13.4 Merck Brompheniramine Sales and Revenue in Global (2017-2022)
7.13.5 Merck Key News
7.14 Tanta Pharmaceuticals
7.14.1 Tanta Pharmaceuticals Corporate Summary
7.14.2 Tanta Pharmaceuticals Business Overview
7.14.3 Tanta Pharmaceuticals Brompheniramine Major Product Offerings
7.14.4 Tanta Pharmaceuticals Brompheniramine Sales and Revenue in Global (2017-2022)
7.14.5 Tanta Pharmaceuticals Key News
8 GLOBAL BROMPHENIRAMINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Brompheniramine Production Capacity, 2017-2028
8.2 Brompheniramine Production Capacity of Key Manufacturers in Global Market
8.3 Global Brompheniramine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 BROMPHENIRAMINE SUPPLY CHAIN ANALYSIS
10.1 Brompheniramine Industry Value Chain
10.2 Brompheniramine Upstream Market
10.3 Brompheniramine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Brompheniramine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Brompheniramine in Global Market
Table 2. Top Brompheniramine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Brompheniramine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Brompheniramine Revenue Share by Companies, 2017-2022
Table 5. Global Brompheniramine Sales by Companies, (K Units), 2017-2022
Table 6. Global Brompheniramine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Brompheniramine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Brompheniramine Product Type
Table 9. List of Global Tier 1 Brompheniramine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Brompheniramine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Brompheniramine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Brompheniramine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Brompheniramine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Brompheniramine Sales (K Units), 2017-2022
Table 15. By Type - Global Brompheniramine Sales (K Units), 2023-2028
Table 16. By Application – Global Brompheniramine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Brompheniramine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Brompheniramine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Brompheniramine Sales (K Units), 2017-2022
Table 20. By Application - Global Brompheniramine Sales (K Units), 2023-2028
Table 21. By Region – Global Brompheniramine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Brompheniramine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Brompheniramine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Brompheniramine Sales (K Units), 2017-2022
Table 25. By Region - Global Brompheniramine Sales (K Units), 2023-2028
Table 26. By Country - North America Brompheniramine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Brompheniramine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Brompheniramine Sales, (K Units), 2017-2022
Table 29. By Country - North America Brompheniramine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Brompheniramine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Brompheniramine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Brompheniramine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Brompheniramine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Brompheniramine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Brompheniramine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Brompheniramine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Brompheniramine Sales, (K Units), 2023-2028
Table 38. By Country - South America Brompheniramine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Brompheniramine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Brompheniramine Sales, (K Units), 2017-2022
Table 41. By Country - South America Brompheniramine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Brompheniramine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Brompheniramine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Brompheniramine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Brompheniramine Sales, (K Units), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Brompheniramine Product Offerings
Table 48. Pfizer Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. AMAG Pharmaceuticals Corporate Summary
Table 50. AMAG Pharmaceuticals Brompheniramine Product Offerings
Table 51. AMAG Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. PAI Corporate Summary
Table 53. PAI Brompheniramine Product Offerings
Table 54. PAI Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. USL Pharma Corporate Summary
Table 56. USL Pharma Brompheniramine Product Offerings
Table 57. USL Pharma Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Watson Laboratories Corporate Summary
Table 59. Watson Laboratories Brompheniramine Product Offerings
Table 60. Watson Laboratories Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Teva Corporate Summary
Table 62. Teva Brompheniramine Product Offerings
Table 63. Teva Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Ivax Pharmaceuticals Corporate Summary
Table 65. Ivax Pharmaceuticals Brompheniramine Product Offerings
Table 66. Ivax Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Newtron Pharmaceuticals Corporate Summary
Table 68. Newtron Pharmaceuticals Brompheniramine Product Offerings
Table 69. Newtron Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Nexgen Pharma Corporate Summary
Table 71. Nexgen Pharma Brompheniramine Product Offerings
Table 72. Nexgen Pharma Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Endo International Corporate Summary
Table 74. Endo International Brompheniramine Product Offerings
Table 75. Endo International Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Novartis Corporate Summary
Table 77. Novartis Brompheniramine Product Offerings
Table 78. Novartis Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Eon Pharma Corporate Summary
Table 80. Eon Pharma Brompheniramine Product Offerings
Table 81. Eon Pharma Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Merck Corporate Summary
Table 83. Merck Brompheniramine Product Offerings
Table 84. Merck Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Tanta Pharmaceuticals Corporate Summary
Table 86. Tanta Pharmaceuticals Brompheniramine Product Offerings
Table 87. Tanta Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Brompheniramine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 89. Global Brompheniramine Capacity Market Share of Key Manufacturers, 2020-2022
Table 90. Global Brompheniramine Production by Region, 2017-2022 (K Units)
Table 91. Global Brompheniramine Production by Region, 2023-2028 (K Units)
Table 92. Brompheniramine Market Opportunities & Trends in Global Market
Table 93. Brompheniramine Market Drivers in Global Market
Table 94. Brompheniramine Market Restraints in Global Market
Table 95. Brompheniramine Raw Materials
Table 96. Brompheniramine Raw Materials Suppliers in Global Market
Table 97. Typical Brompheniramine Downstream
Table 98. Brompheniramine Downstream Clients in Global Market
Table 99. Brompheniramine Distributors and Sales Agents in Global Market
Table 1. Key Players of Brompheniramine in Global Market
Table 2. Top Brompheniramine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Brompheniramine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Brompheniramine Revenue Share by Companies, 2017-2022
Table 5. Global Brompheniramine Sales by Companies, (K Units), 2017-2022
Table 6. Global Brompheniramine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Brompheniramine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Brompheniramine Product Type
Table 9. List of Global Tier 1 Brompheniramine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Brompheniramine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Brompheniramine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Brompheniramine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Brompheniramine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Brompheniramine Sales (K Units), 2017-2022
Table 15. By Type - Global Brompheniramine Sales (K Units), 2023-2028
Table 16. By Application – Global Brompheniramine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Brompheniramine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Brompheniramine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Brompheniramine Sales (K Units), 2017-2022
Table 20. By Application - Global Brompheniramine Sales (K Units), 2023-2028
Table 21. By Region – Global Brompheniramine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Brompheniramine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Brompheniramine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Brompheniramine Sales (K Units), 2017-2022
Table 25. By Region - Global Brompheniramine Sales (K Units), 2023-2028
Table 26. By Country - North America Brompheniramine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Brompheniramine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Brompheniramine Sales, (K Units), 2017-2022
Table 29. By Country - North America Brompheniramine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Brompheniramine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Brompheniramine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Brompheniramine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Brompheniramine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Brompheniramine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Brompheniramine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Brompheniramine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Brompheniramine Sales, (K Units), 2023-2028
Table 38. By Country - South America Brompheniramine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Brompheniramine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Brompheniramine Sales, (K Units), 2017-2022
Table 41. By Country - South America Brompheniramine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Brompheniramine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Brompheniramine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Brompheniramine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Brompheniramine Sales, (K Units), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Brompheniramine Product Offerings
Table 48. Pfizer Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. AMAG Pharmaceuticals Corporate Summary
Table 50. AMAG Pharmaceuticals Brompheniramine Product Offerings
Table 51. AMAG Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. PAI Corporate Summary
Table 53. PAI Brompheniramine Product Offerings
Table 54. PAI Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. USL Pharma Corporate Summary
Table 56. USL Pharma Brompheniramine Product Offerings
Table 57. USL Pharma Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Watson Laboratories Corporate Summary
Table 59. Watson Laboratories Brompheniramine Product Offerings
Table 60. Watson Laboratories Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Teva Corporate Summary
Table 62. Teva Brompheniramine Product Offerings
Table 63. Teva Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Ivax Pharmaceuticals Corporate Summary
Table 65. Ivax Pharmaceuticals Brompheniramine Product Offerings
Table 66. Ivax Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Newtron Pharmaceuticals Corporate Summary
Table 68. Newtron Pharmaceuticals Brompheniramine Product Offerings
Table 69. Newtron Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Nexgen Pharma Corporate Summary
Table 71. Nexgen Pharma Brompheniramine Product Offerings
Table 72. Nexgen Pharma Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Endo International Corporate Summary
Table 74. Endo International Brompheniramine Product Offerings
Table 75. Endo International Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Novartis Corporate Summary
Table 77. Novartis Brompheniramine Product Offerings
Table 78. Novartis Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Eon Pharma Corporate Summary
Table 80. Eon Pharma Brompheniramine Product Offerings
Table 81. Eon Pharma Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Merck Corporate Summary
Table 83. Merck Brompheniramine Product Offerings
Table 84. Merck Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Tanta Pharmaceuticals Corporate Summary
Table 86. Tanta Pharmaceuticals Brompheniramine Product Offerings
Table 87. Tanta Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Brompheniramine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 89. Global Brompheniramine Capacity Market Share of Key Manufacturers, 2020-2022
Table 90. Global Brompheniramine Production by Region, 2017-2022 (K Units)
Table 91. Global Brompheniramine Production by Region, 2023-2028 (K Units)
Table 92. Brompheniramine Market Opportunities & Trends in Global Market
Table 93. Brompheniramine Market Drivers in Global Market
Table 94. Brompheniramine Market Restraints in Global Market
Table 95. Brompheniramine Raw Materials
Table 96. Brompheniramine Raw Materials Suppliers in Global Market
Table 97. Typical Brompheniramine Downstream
Table 98. Brompheniramine Downstream Clients in Global Market
Table 99. Brompheniramine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Brompheniramine Segment by Type
Figure 2. Brompheniramine Segment by Application
Figure 3. Global Brompheniramine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Brompheniramine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Brompheniramine Revenue, 2017-2028 (US$, Mn)
Figure 7. Brompheniramine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Brompheniramine Revenue in 2021
Figure 9. By Type - Global Brompheniramine Sales Market Share, 2017-2028
Figure 10. By Type - Global Brompheniramine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Brompheniramine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Brompheniramine Sales Market Share, 2017-2028
Figure 13. By Application - Global Brompheniramine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Brompheniramine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Brompheniramine Sales Market Share, 2017-2028
Figure 16. By Region - Global Brompheniramine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Brompheniramine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Brompheniramine Sales Market Share, 2017-2028
Figure 19. US Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Brompheniramine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Brompheniramine Sales Market Share, 2017-2028
Figure 24. Germany Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 25. France Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Brompheniramine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Brompheniramine Sales Market Share, 2017-2028
Figure 33. China Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 37. India Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Brompheniramine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Brompheniramine Sales Market Share, 2017-2028
Figure 40. Brazil Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Brompheniramine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Brompheniramine Sales Market Share, 2017-2028
Figure 44. Turkey Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Brompheniramine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Brompheniramine by Region, 2021 VS 2028
Figure 50. Brompheniramine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Brompheniramine Segment by Type
Figure 2. Brompheniramine Segment by Application
Figure 3. Global Brompheniramine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Brompheniramine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Brompheniramine Revenue, 2017-2028 (US$, Mn)
Figure 7. Brompheniramine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Brompheniramine Revenue in 2021
Figure 9. By Type - Global Brompheniramine Sales Market Share, 2017-2028
Figure 10. By Type - Global Brompheniramine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Brompheniramine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Brompheniramine Sales Market Share, 2017-2028
Figure 13. By Application - Global Brompheniramine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Brompheniramine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Brompheniramine Sales Market Share, 2017-2028
Figure 16. By Region - Global Brompheniramine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Brompheniramine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Brompheniramine Sales Market Share, 2017-2028
Figure 19. US Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Brompheniramine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Brompheniramine Sales Market Share, 2017-2028
Figure 24. Germany Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 25. France Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Brompheniramine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Brompheniramine Sales Market Share, 2017-2028
Figure 33. China Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 37. India Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Brompheniramine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Brompheniramine Sales Market Share, 2017-2028
Figure 40. Brazil Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Brompheniramine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Brompheniramine Sales Market Share, 2017-2028
Figure 44. Turkey Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Brompheniramine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Brompheniramine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Brompheniramine by Region, 2021 VS 2028
Figure 50. Brompheniramine Industry Value Chain
Figure 51. Marketing Channels
